Browse by Poster Session

LBS01.01 - Nasopharyngeal Carcinoma Exosomes Modify the Metabolism Status of Human Dendritic Cells and Favour their Recruitment through the CCL20 Chemokine

LBS01.02 - Cytotoxic T Lymphocyte EV that Prevents Tumor Metastasis by Collapse of Tumoral Mesenchymal Stroma is classified into Exosome, but not Microvesicle or Apoptotic Body.

LBS01.04 - The application of flow cytometry in an EV-based liquid biopsy for the detection of Cancer Multidrug Resistance in Myeloma

LBS01.05 - Photodynamic Therapy using a New Folate-targeted Photosensitizer on Peritoneal Ovarian Cancer Cells Induces the Release of Extra-cellular Vesicules with Immunoactivating Properties

LBS01.06 - Metabolomic profiling of serum and exosomes isolated from head and neck cancer patients after radiotherapy

LBS01.07 - Proteomic profiling of small extracellular vesicles secreted by human pancreatic cancer cells implicated in cellular transformation

LBS01.08 - Proteomic profile of tumor-derived exosomes in plasma of melanoma patients

LBS01.09 - Isolation and characterization of prostate-derived extracellular vesicles as a liquid biopsy strategy in cancer diagnosis

LBS01.10 - Paving the way for implementing a feasible and reliable technique for assessing urinary extracellular vesicles as biomarkers for bladder cancer in clinical practice

LBS01.11 - The role of small extracellular vesicles secreted by cells with extra centrosomes in PDAC microenvironment remodelling

LBS01.12 - Exosomal Carboxypeptidase E confers and CPE-shRNA loaded exosomes inhibit growth and invasion of hepatocellular carcinoma cells.

LBS01.13 - Stress hormones promote prostate cancer aggressiveness through modulation of mir-628-5p expression and exosome release

LBS02.04 - Single Extracellular Vesicle Trapping by Aptamer-Au Nanoparticle Mediated Au Superlattices

LBS02.06 - Secreted protein of MSC: Adipose vs Umbilical Cord Tissue

LBS02.07 - Development of scalable monolith chromatography processes for the purification of exosomes from a clinically relevant stem cell product

LBS02.08 - Using degron-tagged reporters to specifically label and track extracellular vesicles in vivo

LBS02.09 - Heterogeneity and batch variation of HEK293 extracellular vesicles

LBS03.4 - GMP compatible angiogenic exosome processing toward therapeutic for treating stroke

LBS03.5 - Neuronal-origin plasma EVs provide biomarkers for Parkinson’s Disease

LBS03.7 - Urinary extracellular vesicles as biomarkers of kidney allograft injury: optimization of isolation protocol and characterization

LBS03.10 - Astrocyte-derived extracellular vesicles regulate dendritic spine formation and neuronal network connectivity

LBS03.11 - Enhancement of immunomodulatory functions of MSC-derived extracellular vesicles through modification of up-stream parameters

LBS03.12 - Donor Source Affects Potency of Mesenchymal Stem Cell-derived Extracellular Vesicles

LBS03.13 - Analysis of extracellular vesicle populations from malaria-infected erythrocytes by field-flow fractionation reveal distinct sub-sets

LBS03.14 - Evidences on microalgal extracellular vesicles: a morphological assessment

PF01.02 - Release of larger extracellular vesicles post-acute exercise is associated with the exercise responder phenotype in youth living with obesity

PF01.03 - Using dual-fluorescent reporter mice to track tissue-specific extracellular vesicles

PF01.04 - Endothelial CD36 delivery of FA loaded extracellular vesicles is critical for thermogenesis.

PF01.05 - Nanovesicles from orange juice restore the intestinal functions altered during diet-induced obesity in mice.

PF01.06 - Association, structure, and function of fibronectin in extracellular vesicles from hepatocytes

PF01.07 - Elevated glucose increases soluble and aggregated forms of human islet amyloid polypeptide in islet-derived extracellular vesicles – Implications in type 2 diabetes and islet transplantation

PF01.08 - Contraction, but not glycolysis, regulates the size of skeletal muscle EVs secreted ex vivo.

PF02.03 - Cell-penetrating sC18 peptide-modified extracellular vesicles for intracellular delivery

PF02.05 - Natural or Synthetic: A Comparison of the Efficiency of Extracellular Vesicles vs Synthetic Carriers for RNA Delivery

PF02.09 - The Role of Circulating Extracellular Vesicles in Patients with Chronic Chagas Disease

PF02.10 - Extracellular Vesicles - a Trojan horse for therapeutic agent delivery

PF02.11 - Hybrid extracellular vesicles - biomimetic tool for drug delivery to repair endothelial cell dysfunction

PF03.01 - Investigating the effects of oxidative stress on extracellular vesicle function and cargo loading

PF03.02 - Mutant p53 governs tumor microenvironment dynamics via exosomes and outer membrane vesicles

PF03.03 - S. oneidensis vesicle loading is driven by BAR domain protein and outer membrane cytochrome interplay

PF03.04 - Enhancement of intestinal IgA production via Peyer’s patch dendritic cells by membrane vesicles derived from lactic acid bacteria (Lactobacillus sakei)

PF03.05 - Identification and evaluation of potential new biomarkers of trematode infections in Extracellular Vesicles

PF03.06 - Life stage-specific glycosylation of schistosome-derived extracellular vesicles

PF03.07 - Isolation and characterization of Extracellular Vesicles from phloem sap reveals their possible role in defense against phloem-feeding insects

PF03.08 - Extracellular vesicles from nematode species Heligmosomoides bakeri and Trichuris muris contain distinct small RNAs that could enable niche specificity in the host

PF04.05 - Identification of novel EV-associated miRNAs as toxic biomarkers in mouse

PF04.07 - Cancer-specific genomic alterations in plasma large EVs from patients with advanced cancer

PF04.08 - Detection of EGFR mutations in exosomal RNA and protein mirrors disease status in metastatic lung cancer patients

PF04.09 - Identification of plasma-derived, EV-based biomarkers for glioblastoma

PF04.12 - Identification of a saliva exosomal RNA signature for Sjogren’s syndrome

PF04.14 - Endometrial fluid derived EVs as low invasive diagnostic biomarkers of implantative endometrium

PF04.16 - Small RNA cargo of EVs is affected by hormone treatment in prostate cancer

PF05.02 - Detection of PD-L1 in circulating extracellular vesicles

PF05.04 - Validation of antibodies on western blot for extracellular vesicles from biological human samples and cancer cell conditioned media

PF05.08 - Proteomic study of mesenchymal stem cells derived exosomes modified using miR.

PF05.11 - A Novel Extracellular Vesicle Isolation Method Used to Discover Urine Liver Disease Biomarkers

PF05.12 - Evaluation of plasma extracellular vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus

PF05.13 - Using extracellular vesicles as a template for autoimmune diagnostic screening

PF05.16 - Porcine body fluids differ in small extracellular vesicle counts: comparison of blood plasma, seminal plasma and cerebrospinal fluid as vesicle sources for proteomic analyses

PF05.18 - Identification of potential pancreatic cancer therapeutic targets in the cargo of extracellular vesicles released by human macrophages

PF06.02 - In vivo derived bovine blastocyst secrete different population of extracellular vesicles compared to vitro produced counterparts

PF06.03 - Extracellular vesicles as messengers in early embryo-maternal communication

PF06.04 - Arrdc4-dependent extracellular vesicle biogenesis is required for sperm maturation

PF06.05 - Maternal EV-derived myomiRs are associated with the development of large-for-gestational age babies in pregnancies complicated by gestational diabetes

PF06.06 - A new type of nanovesicles in seminal plasma: the myelinosomes

PF07.02 - Extracellular vesicles derived from human amniotic fluid stem cells: characterization and therapeutic effect in a model of chronic kidney disease

PF07.03 - A millifluidic in vitro model of glomerular filtration to test the regenerative effect of extracellular vesicles under dynamic conditions

PF07.04 - Extracellular vesicles from kidney cancer tissue and comparison of two quantitative methods

PF07.05 - Tetraspanins on Serum derived-EVs Enable Detection of Renal Cell Carcinoma

PF07.06 - Extracellular Vesicles as a Source of Cancer Biomarkers in the Urine of Urothelial Carcinoma Patients: characterization of a two-step protocol for the isolation of urine-derived EVs

PF08.01 - Extracellular vesicles are involved in the expansion of the mesenchymal signature in glioblastoma tumours

PF08.02 - Inhibition of extracellular vesicle release in triple negative breast cancer

PF08.05 - Extracellular vesicles from highly metastatic lung cancer cells induce barrier impairment, permeability, and epithelial-to-mesenchymal plasticity in a 16-day mature bronchial epithelium

PF08.06 - Grp78 plays a crucial role in the extracellular vesicle-promoted radioresistance of irradiated head and neck cancer cells

PF08.09 - 3D modeling of EV release in progressing prostate cancer

PF08.10 - Multiplex analysis of renal cell carcinoma cell extracellular vesicles to identify potential clinically relevant markers

PF08.11 - Low molecular weight protein tyrosine phosphatase (LMWPTP) carried by colorectal cancer cells-derived extracellular vesicles as a player in tumor-educated human fibroblast

PF08.15 - Exosomal miR-181a Inhibition by Vincristine and Prednisone in Pediatric Acute Lymphoblastic Leukemia.

PF08.16 - Secreted extracellular vesicles from renal cell carcinoma cells

PF08.17 - Tumor cell-derived small extracellular vesicles modulate macrophage immunosuppressive phenotype associated with PD-L1 expression

PF08.18 - Exosomes synthesizing HER2 miRNA and engineered to adhere to HER2 on tumor cells surface exhibit enhanced anti-tumor activity

PF08.19 - Systematic Characterization of Ovarian Cancer-derived Exosomes Unveil miRNAs Interfering with CD8+ T Cell Activation

PF08.20 - Irradiation of breast cancer cells alters the quality of DNA cargo in the exosomes that they produce

PF08.21 - IRE1 inhibition modulates immune phenotype of triple negative breast cancer cells and cancer-derived extracellular vesicles

PF09.02 - Extracellular vesicles from patients with sickle cell disease disrupt gap junctions

PF09.03 - The effects of platelet concentrate storage time on extracellular vesicle interactions associated with fibrin clot formation in-vitro

PF09.04 - Characterization of miRNA from serum derived exosomes in a mouse tibia fracture model of Complex Regional Pain Syndrome

PF09.05 - Extracellular Vesicle-based liquid biopsy in Acute Myeloid Leukaemia: a reliable source of residual disease biomarkers?

PF10.01 - Profiling mRNAs of parental prostate cancer cells with different phenotypes and their daughter extracellular vesicles using the NanoString low RNA input nCounter assay

PF10.05 - Cancer cell-derived EVs containing alphaV beta6 Integrin regulate CD163, IL-6 and IL-10 levels in peripheral blood mononuclear cells

PF10.09 - Antifungal antibiotic activity of outer membrane vesicles from adherent Lysobacter enzymogenes C3 against therapeutic and biocontrol targets.

PF10.10 - Elucidating the cellular uptake and tissue distribution mechanism of cell derived vesicles, a novel therapeutic carrier

PF10.11 - Myofibroblasts-derived microvesicles increase dermal fibroblasts collagen production through PLGF-1

PF10.12 - Structural Insights on Fusion Mechanisms of Extracellular Vesicles with Model Plasma Membranes

PF11.02 - Platelet Enhanced Plasma: A Novel Extracellular Vesicle Enriched Resuscitation Fluid?

PF11.06 - miRNAs enriched in extracellular vesicles isolated from plasma- and serum-based autologous blood-derived products for osteoarthritis therapy

PF11.08 - Protective role of shiitake mushroom-derived exosome-like nanoparticles in D-galactosamine and lipopolysaccharide-induced acute liver injury in mice

PF11.10 - Approaches to Assess Clinically Available Exosomes' Quality and Safety

PF11.11 - Engineering Pro-Healing EV Cargo Using a Closed-System Bioreactor.

PF11.12 - Comprehensive analysis of methods and outcome reporting in preclinical animal studies of mesenchymal stem cell derived extracellular vesicles: A systematic review

PF11.15 - Cell derived vesicles: Unraveling the science of novel vesicles with therapeutic promises

PF11.16 - Antifibrotic properties of extracellular vesicles derived from human induced pluripotent stem cells

PF11.17 - Induced pluripotent stem cells- derived extracellular vesicles ameliorates D-galactosamine and lipopolysaccharide induced acute liver failure

PF11.18 - MSC-derived extracellular vesicles promote human cartilage regeneration by control of autophagy

PF11.19 - Large-scale preparations of small extracellular vesicles from conditioned media of mesenchymal stromal cells modulate therapeutic impacts on a newly established Graft-versus-Host-Disease model in batch dependent manners

PF11.20 - Milk Extracellular Vesicles Can Repair Malnutrition-induced Gut Barrier Dysfunction

PF11.22 - Outer Membrane Vesicles from Photobacterium damselae subsp. piscicida: characterization and antigenic potential

PF12.01 - Comparison of Extracellular Vesicle Isolation Methods from Small Volumes of Urine for Radiation Metabolomics Analysis.

PF12.07 - An extracellular small RNA-seq data processing pipeline optimized for high-performance computing

PF12.09 - Characterization of extracellular vesicles (EVs) derived from Peripheral Blood Mononuclear Cells (PBMCs) of Inflammatory Bowel Disease (IBD) patients

PF12.10 - Proteomic analysis of exosomes isolated using precipitation and column-based approaches

PF13.02 - From total plasma EVs to immuno-captured neuronal EVs - yield, purity and enrichment

PF13.03 - Characterisation of breath exosomes: towards non-invasive diagnosis

PF13.05 - A Novel but Simple Method to Obtain Purified Exosomes by One-Step Ultracentrifugation

PF13.07 - A straightforward device to extract apoplastic fluid from succulent fruits for higher purity of extracellular vesicles

PF13.08 - Method to Simultaneously Capture Multiple Classes of Intact Extracellular RNA Carriers Including Extracellular Vesicles and Lipoprotein Particles

PF13.09 - Optimizing the isolation of placental mesenchymal stromal cell-derived extracellular vesicles in a 3D bioreactor system

PF13.11 - Assessment of Various Extracellular Vesicle Isolation Methods Through Chemical Analysis with Surface-Enhanced Raman Spectroscopy

PF13.12 - Bioreactors: lessons to develop an Extracellular Vesicle factory

PF13.13 - Rapid and efficient isolation of extracellular vesicles by Phosphate−DNA−Cholesterol functionalized defected Metal Organic Framework

PF14.02 - Site-specific integration enables rapid cell engineering for the development of precision extracellular vesicle therapeutics

PF14.03 - Transport of Outer Membrane Vesicles as a Model Therapeutic Delivery System in Pathogenic and Commensal Bacteria

PF14.04 - Utilizing a Gaucher’s Disease Cell Line for the Evaluation of a Novel Exosome-Based Replacement Therapy

PF14.06 - ThRxosomes: A Novel Exosomes Based Theranostic for Lung Cancer

PF14.08 - Exosome-modified nanoparticles as an alternative delivery system for small RNAs in cancer therapy

PF14.09 - Microglial Extracellular Vesicles as Therapeutic Vector for Neuroinflammation

PF14.10 - Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple negative breast cancer via extracellular vesicle reprogramming

PF15.01 - Statins decrease the implantation and invasion of high-grade serous ovarian cancer cells induced by exosomes by altering its composition and its cell uptake and the endocytic traffic at the metastatic niche.

PF15.02 - Label-free optical imaging and characterization of cancer-associated extracellular vesicles in tissues

PF15.05 - Educated osteoblasts regulate breast cancer proliferation via small extracellular vesicles

PF15.06 - Phosphorylation of Tyrosine 23 in Annexin A2 is Essential for its Association with Exosomes and for Imparting Invasive and Proliferative Capacity to other Cells

PF15.07 - A novel method for epithelial-derived extracellular vesicle isolation and enrichment in patients with advanced prostate cancer

PF15.11 - Exosomes drive medulloblastoma metastasis in a MMP2 and EMMPRIN dependent manner

PF15.12 - Anti-migratory effect of Nm23-H1 via exosomes

PF16.02 - Syndecan-1 Regulates Alveolar Type 2 Epithelial Cell Senescence Mediating Through Extracellular Vesicles During Lung Fibroproliferation

PF16.03 - Immortalized Cardiosphere-Derived Cell EV-associated piRNA, imEV-Pi, protects against ischemic injury in the heart

PF16.06 - Mechanisms of host resistance to plasma membrane damage induced by pneumolysin attack

PF17.01=OP2.01 - Development of scalable processes to produce therapeutic mesenchymal stromal cell-derived extracellular vesicles and their characterization

PF17.03=OP2.03 - Concentration measurements by nanoparticle tracking analysis strongly depend on the particle refractive index

PF17.04=OP2.04 - Evaluation of three different isolation methods for small extracellular vesicles from human plasma in prostate cancer diagnosis

PF17.05=OP2.05 - Multiplexed surface protein profiling of tumor-derived extracellular vesicles by an electrokinetic sensor

PF17.07=OP2.07 - Optimized immunocapture methods for the direct detection of EV tumour associated proteins in biological fluids: playing around with biophysics

PF17.08=OP2.08 - Normalized extravesicular protein expression profiles on antibody microarrays reveal protein associations in EVs of organotropic and metastatic breast cancer cell lines

PF17.09=OP2.09 - Heparan sulphate proteoglycans are required for EV-mediated delivery of multiple growth factors

PF17.12=OP2.12 - Robust exosomal biomarker panel discovery in ovarian cancer using machine learning approaches and studying miRNA & miRNA-target interactions

PS01.01 - Ethanol and HIV-induced exosome from hepatocytes activate hepatic stellate cells

PS01.02 - Antimicrobial peptide LL-37 induces neutrophil-derived extracellular vesicles with antibacterial potential and protects murine sepsis

PS01.03 - Identification of miRNA profiles of serum exosomes in active tuberculosis

PS01.04 - The new therapy to treatment experimental Acute Chagas Disease

PS01.09 - Characterization of outer membrane vesicle-carried proteins as pathogenicity factors from Acinetobacter baumannii

PS01.10 - Talaromyces marneffei yeasts-derived Extracellular Vesicles Mediate Inflammatory Response and Modulate Macrophage Functions

PS01.11 - Plasma-derived extracellular vesicles as potential biomarkers in chronic Chagas disease patients

PS01.12 - Eukaryotic extracellular vesicles and prokaryotes – a different perspective

PS01.13 - Hydrogen sulfide (H2S) derived extracellular vesicles: a potential protective role in response to respiratory syncytial virus (RSV) infection

PS01.14 - Effects of extracellular vesicle-mediated transmission on Reoviridae infection

PS01.15 - Multiparameter flow cytometry analysis of the human spleen and its interaction with plasma-derived EVs from Plasmodium vivax patients

PS02.01 - Activating protein-1 and extracellular vesicles in cancer metastatic behavior phenocopying

PS02.02 - Neuroblastoma-secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone marrow mesenchymal stromal cells

PS02.03 - Effects of Small-Extracellular Vesicles on cell biomechanical properties in metastatic breast cancer

PS02.04 - Stratification of angiogenic or non-angiogenic lesions in colorectal cancer liver metastases patients using extracellular vesicle miRNA

PS02.06 - The role of extracellular vesicles from cancer cells in bone metastasis

PS02.11 - Extracellular vesicles from prostate cancer cells deliver microRNAs to promote osteogenesis

PS02.12 - Proteomic Profiling of Retinoblastoma-Derived Exosomes reveals potential biomarkers of vitreous seeding

PS02.14 - Activation of hepatic stellate cells by extracellular vesicles released by uveal melanoma cells

PS03.01 - Proteomic Analysis of Amniotic Fluid-Derived Exosome Cargo Reveals a Therapeutic Potential for Regenerative Therapies.

PS03.03 - Generation of CAR-T and γδT Cell-derived Exosomes for Future Cell Free Immunotherapies

PS03.04 - Characterization, composition, and biological properties of extracellular vesicles generated from human induced pluripotent stem cell-derived neural stem cells

PS03.05 - Promise of neural stem cell-derived extracellular vesicles for combating age-associated cognitive and mood impairments

PS03.09 - Evaluation of Osteoinductive and Anti-Inflammatory Properties of Spine-Derived Exosomes

PS03.10 - Administration of human Mesenchymal Stem Cell derived extracellular vesicles modulates the abnormal plasticity of newly born neurons and neuroinflammation in a rat model of status epilepticus

PS03.12 - Equine tendon injury treatment by EVs: an in vitro study

PS03.13 - EV-enriched secretome fraction from GMP-compatible, scalable, human iPSC-derived cardiac progenitors improve heart function in chronic heart failure mice

PS03.14 - Electrospun Collagen Coupled with Spine Bone Marrow-Derived Exosomes

PS03.16 - A Novel Umbilical Cord Derived Wharton’s Jelly Formulation For Regenerative Medicine Applications

PS03.17 - Improvement of immunosuppressive extracellular vesicles by HIF-1alpha overexpression and priming of parental mesenchymal stromal cells

PS03.18 - Collagen sponge loaded with mesenchymal stem cell-derived small extracellular vesicles promote robust bone regeneration

PS03.19 - Immunomodulatory Potential of Extracellular Vesicles Derived from Mesenchymal Stromal Cells

PS03.20 - Extracellular Vesicles in Platelet-rich Plasma: Dependency on Sample Processing

PS03.21 - Satellite Cell-Derived Extracellular Vesicles as a Therapeutic for Mitochondrial Dysfunction in Duchenne Muscular Dystrophy

PS04.05 - Measuring cholesterol as a high-throughput method for quantifying extracellular vesicles

PS04.06 - Optimization of nanoparticle tracking analysis of extracellular vesicles isolated from plasma and bronchopulmonary lavage fluid of patients with non-small cell lung cancer

PS04.08 - Introducing a universal fluorescence extracellular vesicle stain for NanoView Bioscience’s Exoviewer platform

PS04.09 - Membrane labeling is essential for the identification and quantification of extracellular vesicles via FACS

PS04.10 - Surface plasmon field-enhanced fluorescence spectroscopy (SPFS) system for quantitative and qualitative extracellular vesicles total evaluation without any sample pretreatment

PS04.12 - Identification of a novel compound that inhibits small EV secretion and tumor progression by a sensitive ELISA screening.

PS04.13 - Quantitative proteomics identifies proteins enriched in microvesicles and exosomes respectively

PS05.03 - The role of small extracellular vesicles in chronic neuropathic pain

PS05.06 - Large and small extracellular vesicles in ALS: friends or foes?

PS05.08 - Combining high-resolution flow cytometry and surface marker analysis using an automated platform to study extracellular vesicle in cerebrospinal fluid

PS05.09 - A distinct microRNA signature in plasma derived small extracellular vesicles of different neurodegenerative diseases

PS05.12 - Role of exosomes in the development of dendritic filopodia, spines and synapses

PS05.13 - Effects of apolipoprotein E genotype on protein and small RNA profiles of brain tissue-derived extracellular vesicles of Alzheimer’s disease patients

PS05.16 - Differences in circulating number of extracellular vesicles between contact sport athletes with and without acute mTBI: a pilot study

PS05.17 - Plasma-derived Extracellular Vesicles profiling as a biomarker for Parkinson’s Disease

PS05.18 - Separation and characterization of extracellular vesicles from human cerebrospinal fluid

PS06.01 - Release of extracellular vesicles from platelets requires platelet-platelet interaction

PS06.04 - Age-dependent alteration in concentration and size distribution of extracellular vesicles in plasma of normotensive and hypertensive rats

PS06.05 - microRNA profiling of circulating extracellular vesicles is involved with susceptibility to age-related diseases: relevance to cardiovascular signaling in aging process

PS06.07 - Endothelial cell-derived extracellular vesicles induce a smooth muscle cell pro-inflammatory phenotype via HMGB1

PS06.10 - Cardiac-derived Extracellular Vesicles Contribute to Communication between Heart and Brain in Chronic Heart Failure (CHF) and Target Nrf2/ARE Signaling

PS06.11 - Ischemia impairs the ubiquitin-mediated secretion of Cx43 into extracellular vesicles

PS06.12 - Cardioprotection mediated by calcium-ionophore induced extracellular vesicles

PS07.02 - Optimization of Urinary Extracellular mRNA Profiling during Pregnancy

PS07.03 - IL-2 mutein-induced changes of exosomal miRNA cargo in a humanized mouse model

PS07.05 - Identification of potential biomarkers in microglial specific exosomes isolated from prion-infected serum

PS07.06 - Comparison of urinary extracellular vesicle isolation methods for transcriptomic biomarker research in diabetic kidney disease

PS07.07 - cfDNA distribution in bioliquids: exosome-associated vs. free circulating form

PS07.09 - RNA signatures of mouse primary neurons, astrocytes and their small extracellular vesicles

PS07.10 - Isolation and characterization of Extracellular vesicles (EVs) and EV RNA in human urine samples

PS07.13 - Exosomal mRNA in diagnosis strategy for hepatocellular carcinoma

PS07.14 - Circulating extracellular vesicle signatures in small cell lung cancer

PS08.03 - A fast and reliable in vitro cell culture system reveals that acidification of bovine milk extracellular vesicles impairs their functionality

PS08.04 - Optimising methods for separation and characterisation of extracellular vesicles from skim milk and infant milk formula

PS08.05 - A novel platform to isolate extracellular vesicles based on surface molecule expression uncovers functional differences between EV subpopulations

PS08.06 - Preparation of agarose microspheres for high-efficient separation of extracellular vesicles

PS08.10 - Immunomagnetic Sequential Ultrafiltration (iSUF) Platform for Enrichment and Purification of Extracellular Vesicles from Large and Small Volumes of Biofluid

PS08.12 - Challenges in exosomes isolation from primary biological samples derived from multiple myeloma patients

PS08.14 - Characterization of the extraction of extracellular vesicles using a lab-on-a-disc filtration system

PS08.15 - Effects of Sample Processing on Isolation of Extracellular Vesicles from Blood Plasma by Centrifugation

PS09.01 - Imaging extracellular vesicles arising from apoptotic tumour cells for cancer diagnosis and monitoring

PS09.02 - Casting A Small Netrin: Functional roles of a Novel Surface Factor on Stroma-Derived Extracellular Vesicles in Pancreatic Cancer

PS09.05 - Exosomes carry distinct miRNAs that drive medulloblastoma progression

PS09.08 - Leukemic extracellular vesicles induce inflammatory regulators and suppress hematopoietic stem and progenitor cell function

PS09.10 - Desmoglein 2 modulates extracellular vesicle microRNA content in squamous cell carcinoma

PS09.11 - Cancer cells grown in 3D release distinct extracellular vesicles during tumor growth and invasion

PS09.13 - Exploring Extracellular Vesicles release inhibition in Prostate Cancer

PS09.14 - Patient-derived organoids represent a novel tool to study the effect of intra-tumoral heterogeneity on EV release in non-small cell lung cancer

PS09.15 - Exosome Mediate Heart-Adipocyte Communication after Myocardial Ischemia/Reperfusion and Impairs Adipocyte Endocrine Function

PS09.16 - Pancreatic cancer cell extracellular vesicles drastically alter the behavior of recipient normal pancreas cells

PS09.17 - Plasma extracellular vesicles-miRNAs released by hypoxic cells are associated to pro-tumorigenic and immunosuppressive microenvironment in lung cancer

PS09.20 - Analysing Extracellular Vesicles from Drug-Resistant and Drug-Sensitive Cancer Cells as potential Predictive Biomarkers in the Liquid Biopsy

PS09.21 - Downregulation of Rab27a Expression Correlates with Replication Restriction of Oncolytic Herpes Virus in Tumor Cells

PS09.22 - PS09: EVs in Cancer Pathogenesis

PS10.04 - Raman spectral signature of urinary extracellular vesicles as a diagnostic biomarker for diabetic kidney disease

PS11.04 - Subpopulations of tissue-derived extracellular vesicles – methodological evaluation for vesicle size measurement

PS11.05 - Imaging of human plasma-derived small-extracellular vesicles using Transmission Electron Microscopy and Structured Illumination Microscopy

PS11.08 - Dimensional reduction of multi-parametric flow cytometry data reveals existence of distinct extracellular vesicle subpopulations

PS11.09 - Detection and Quantification of Extracellular Vesicles with Cargo Protein and RNA Using the Amnis® CellStream® Flow Cytometer

PS11.10 - Single EV imaging reveals novel EV biomarkers and DNA cargo

PS12.02 - Pulsed electromagnetic fields potentiate the paracrine function of mesenchymal stem cells for cartilage regeneration

PS12.03 - Effects of extracellular vesicles from blood derivatives on osteoarthritic chondrocytes within an inflammation model

PS12.06 - 1α,25(OH)2D3 Regulates Growth Cartilage Matrix Vesicle microRNAs

PS13.01 - Evaluating the impact of culture conditions on human mesenchymal stromal cell-derived extracellular vesicles molecular fingerprint through FTIR spectroscopy

PS13.02 - Performance Qualification for MicroFlow Cytometers: Understanding technical limitations to improve your research

PS13.03 - Operating guidelines to determine the size and concentration of extracellular vesicles with microfluidic resistive pulse sensing

PS13.04 - Real-time measurements of extracellular vesicles binding kinetics achieved through interferometric imaging in a multiplexed microarray modality

PS13.06 - Spectral methods for EV detection in diabetic renal complications

PS13.08 - In situ Detection of Exosomal microRNA-10b by Fusion with Liposome-Encapsulated Nanomotor

PS13.09 - Isolation of exosomes by membrane affinity column increases non-exosomal RNA recovery in comparison to differential ultracentrifugation

PS13.10 - Fluorescent Extracellular Vesicle characterisation using a long lasting cell tracker probe

PS13.11 - Multiplex Electrochemiluminescence Immunoassays for Phenotyping of Intact Extracellular Vesicles (EVs)

PS13.12 - Detection of MISEV recommended EV protein-markers using automated western blotting

PS13.13 - AL-PHA beads: a library of extracellular vesicle-associated metalloproteinase biosensors

PS15.01=OP3.01 - Mitovesicles: a new extracellular vesicle of mitochondrial origin altered in aging and neurodegeneration

PS15.02=OP3.02 - Reducing extracellular vesicle release with a novel neutral sphingomyelinase 2 inhibitor for the treatment of Alzheimer’s disease

PS15.03=OP3.03 - Profiling EVs in the anterior cingulate cortex of individuals with major depressive disorder

PS15.05=OP3.05 - L1CAM is not associated with extracellular vesicles in cerebrospinal fluid or plasma

PS15.06=OP3.06 - An in vitro and in vivo perspective on the role of erythrocyte-derived extracellular vesicles in Parkinson's disease pathology

PS15.07=OP3.07 - Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity

PS15.08=OP3.08 - Dissecting the heterogeneity of extracellular vesicle sub-populations at single vesicle level

PS15.09=OP3.09 - Proteomic analysis of EVs from the filamentous fungal plant pathogens Fusarium graminearum and Fusarium oxysporum f. sp. vasinfectum

PS15.10=OP3.10 - Trypanosoma cruzi releases different types of extracellular vesicles that distinctly modulate host cells

PS15.11=OP3.11 - Commensal bacterial extracellular vesicles act as carriers for norovirus

PS15.13=OP3.13 - Detection of Bacterial Extracellular Vesicles in Blood from Healthy Volunteers

PT01.01 - miR-451a highly expressed in extracellular vesicles secreted from Human fetal mesencephalic neural progenitor cells is one of key therapeutic factors for Parkinsonism multiple system atrophy

PT01.03 - Patterns of apolipoproteins J , D and oxidative markers in circulating extracellular vesicles from MCI and Alzheimer’s patients

PT01.04 - Extracellular vesicle biomarkers of complement activation and synaptic loss in Multiple Sclerosis

PT01.05 - Methylglyoxal and glyoxal affect the protein cargoes in neuronal-derived extracellular vesicles

PT01.07 - A method for exosomal RNA extraction from paired human brain and blood specimens

PT01.08 - MicroRNAs from Adipocyte-derived Small Extracellular Vesicles are Associated with Neurodegeneration

PT01.10 - Expression of Extracellular Vesicles after acute Traumatic Brain Injury: An Exploratory Flow-Cytometry Study

PT01.11 - Enrichment of miR-451a in CNS extracellular vesicles following impairment of the blood brain barrier

PT01.14 - Astrocyte-derived extracellular vesicles in morphine tolerance

PT01.15 - Biophotonics-based platforms for the evaluation of circulating extracellular vesicles as biomarkers of neurodegeneration in Alzheimer’s disease

PT01.16 - Raman profiling of extracellular vesicles as new blood-based biomarker for brain disorders: focus on Parkinson’s disease

PT01.17 - Impact of circulating extracellular vesicles on brain functions and behaviors

PT01.18 - MicroRNA profile of circulating extracellular vesicles are associated with upregulation of neuroinflammatiory signaling pathway in aged animals

PT02.01 - Keratinocyte-derived exosomal packaging drives conversion of injury-site macrophage in granulation tissue of murine wound

PT02.03 - Extracellular vesicles in human milk expose tissue factor and promote coagulation

PT02.04 - Scalable isolation of EVs from different probiotic strains with potential as cosmetic ingredients

PT02.07 - Acerola derived exosome-like nanovesicles enhances the repair of ultraviolet B-induced DNA damage in cultured skin fibroblasts

PT03.01 - EV-mediated HOTAIR delivery for increased angiogenesis

PT03.02 - Nanomaterial labeling of exosomes for cell biology

PT03.03 - Loading of goat´s whey extracellular vesicles with spiked microRNA and curcumin as an strategy for developing new nanocarriers for acellular therapies

PT03.04 - Development of novel tool for purification and characterization of extracellular vesicles in ageing and disease

PT03.05 - Engineering exosomes with GATA-4

PT03.06 - Chinese hamster ovary cells engineered for production of GFP-loaded extracellular vesicles

PT03.07 - Manufacturing Extracellular Vesicles Derived from Human Mesenchymal Stromal Cells (MSC) in Bioreactors for Cancer Therapy

PT03.08 - Biodistribution and cellular location of inhaled exosomes and liposomes in the lung

PT03.10 - Transfection reagent artifact accounts for some reports of extracellular vesicle function

PT04.03 - Characterization of Extracellular vesicles separated from biospecimens of former national football League players at a risk for chronic traumatic encephalopathy

PT04.04 - Density-based fractionation of urine to unravel the proteome landscape of extracellular vesicles in prostate cancer

PT04.06 - Immunoglobulin A coating of feces-derived bacterial vesicles as a marker of inflammatory bowel disease in humans

PT04.11 - Quality control for bacterial EVs

PT04.12 - Relationship of extracellular vesicle cargo with clinical markers of mortality and race

PT04.13 - Repurposing specialised cell-free DNA blood collection tubes for extracellular vesicle isolation

PT04.14 - Role of exosomes in the management of cellular disease in the genetic susceptible participants in the Chilean population

PT04.15 - Subpopulations of EVs in serum and plasma

PT04.17 - Effect of nicotine and menthol on cytochrome P450 and antioxidant enzymes in rat plasma-derived extracellular vesicles

PT04.18 - Proteomic signatures in breast cancer exosomes and cell lines

PT04.19 - Circulatory EVs as potential biomarkers of HIV-drug abuse interactions and neurological dysfunction in HIV-Infected subjects and alcohol/tobacco Users

PT04.20 - Electrochemical detection of miRNA-21-5p

PT05.02 - Clinically relevant synthetic reference materials to standardize concentration measurements of extracellular vesicles: state-of-the-art and future prospects

PT05.03 - Comparison of Production and Activity of Amniotic Fluid Stem Cell Extracellular Vesicles from 3D Hollow Fiber Bioreactor and 2D culture.

PT05.04 - Demonstration of High Gain mode in combination with Imaging Flow Cytometry for improved EV analysis

PT05.08 - Ready-to-use, pre-labeled and stable human EVs for validating new standardization procedures of EV concentration measurements

PT05.09 - Understanding Intracellular Fate of EV-delivered Content

PT06.03 - Comparison of classical and imaging flow cytometry platforms for the characterization of stem cell-derived extracellular vesicles

PT06.05 - Exo-cise: Extracellular vesicles enriched from plasma post-exercise promotes myogenesis and neurogenesis

PT06.07 - Extracellular Vesicle Characterization in Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium

PT06.08 - Increased VEGF Secretion from MSC Cell Culture in Normoxic Condition

PT06.09 - Isolation and characterization of exosomes from canine stem cells

PT06.10 - Mesenchymal stem cells-derived exosomes promote in vitro the progression of triple negative breast cancer cells

PT06.11 - Natural killer cell-derived extracellular vesicles have a potent anti-leukemic effect and selectively target the cancer stem cell subpopulation

PT06.15 - The whitening, anti-wrinkle, and wound-healing effects of Extracellular vesicles from Orbicularis oculi muscle-derived stem cells.

PT06.17 - The effect of cell culture media on extracellular vesicle secretion from mesenchymal stem cells and human pluripotent stem cell-derived neurons

PT07.01 - Analytical ultracentrifugation identifies distinct populations of extracellular vesicles (EVs) carrying the evolutionarily-conserved polycystin-2 protein in C. elegans

PT07.02 - C. elegans ciliated sensory neurons release distinct subpopulations of extracellular vesicles

PT07.03 - Ceramide accumulation induces exosome secretion through lysosomal protein LAPTM4B

PT07.05 - Evaluation of culture conditions on the presence of Ago2 in extracellular vesicles

PT07.09 - Lysosomotropic agents prompts the release of extracellular vesicles carrying autophagy-associated markers: evidence of a general mechanism of secretion driven by lysosomal impairment

PT07.10 - Roles of Extracellular Vesicles for Lenalidomide-Resistance in Multiple Myeloma

PT07.11 - Study on Biological Stimulate Mechanism of Stem cell-derived Exosome Generation by Nanoparticles

PT07.12 - Theoretical description of formation of extracellular vesicles by budding of membrane

PT07.13 - Role of Arrdc4-mediated ubiquitination in extracellular vesicle biogenesis and protein trafficking

PT08.01 - A 3D-printed model to represent the structure and nature of extracellular vesicles, for public engagement and education events.

PT08.02 - Centrifugal filtration-SEC is promising for extracellular vesicle isolation from D492 and D492HER2+ breast epithelial cell lines

PT08.03 - Customer stories from the EV Core of University of Helsinki

PT09.01 - Air pollution exposure and allergic rhinitis exacerbation: the role of nasal microbiota and extracellular vesicle communication

PT09.03 - Aryl hydrocarbon receptor activation induces the expression of specific MicrorRNAs in Th17 cells that are release into extracellular vesicules and associated with arthritis

PT09.08 - Extracellular Vesicles released by Trypanosoma cruzi trypomastigotes under different stress conditions

PT09.09 - Immuno-toxicological Evaluation of Human Mesenchymal Stem Cell-derived Extracellular Vesicles

PT09.11 - Investigation of immune response to mesenchymal stem cell-derived extracellular vesicles in the cancer setting

PT09.12 - Outer membrane vesicles of Mycobacterium avium modulate inflammatory response in monocytes

PT09.13 - Sepsis Alters the Differential Expression of microRNA in Platelet-Derived Small Extracellular Vesicles of Pediatric Patients

PT09.15 - Treg-Derived IL35-Coated Extracellular Vesicles Promote Infectious Tolerance

PT09.16 - Unique formulated dual targeting antigen specific and delivered miRNA-150 gene regulating exosomes acting at the immune synapse to induce APC-derived secondary suppressive exosomes

PT09.17 - The role of Mac-1 and calcium signaling in the formation of neutrophil granulocyte derived extracellular vesicles

PT09.18 - Extracellular vesicles and their microRNA cargo in retinal health and degeneration: mediators of homeostasis, and immune modulation

PT09.19 - Impacts of Agricultural Dust Exposure on Human Lung-Resident Mesenchymal Stromal/stem Cells and their Extracellular Vesicles

PT10.05 - Benchmarking flow cytometric analysis of nanoparticles: a cross-platform study for single extracellular vesicle detection

PT10.08 - Correlation between size and protein expression of single exosomes by combined atomic force and fluorescence microscopy

PT10.09 - Development of a panel of antibodies for capture and labeling of EVs from neural cell types

PT11.01 - Association between circulating extracellular vesicles and thrombogenic risk markers for cardiovascular disease

PT11.02 - Beyond stem cells: extracellular vesicles from human induced pluripotent stem cells (hiPSC) and hiPSC-cardiomyocytes as therapeutic approaches for heart failure

PT11.03 - Endothelial cells differentially load and secrete extracellular vesicle-derived microRNAs into apical and basolateral compartments

PT11.08 - Insights into EV subpopulations positive and negative for Annexin A1 from smooth muscle cells and valvular interstitial cells

PT11.10 - Postoperative plasma exosomal miR-21 and miR-133a signature in patients with left ventricular reverse remodeling after surgical mitral valve repair

PT11.11 - Expression of lipocalin-2 (LCN2) in circulating extracellular vesicles (EVs) and femoral plaque-derived EVs of peripheral arterial disease patients.

PT11.12 - Cardioprotective effects of extracellular vesicles from immortalized parental stromal cells: a translational strategy

PT12.02 - Characterization of melanocytic extracellular vesicles during aging of the choroid

PT12.03 - Extracellular vesicle heterogeneity and the impact of cellular phenotypic drift on the vesicular proteome

PT12.05 - In vivo tracking and biodistribution analysis of mesenchymal stem cell-derived extracellular vesicles in a radiation injury murine model

PT12.08 - Regulation of cellular senescence by Interferon Induced Transmembrane Protein 3 contained in small Extracellular Vesicles

PT12.11 - Tridimensional fibroblast culture revealed a novel exososome-dependent extracellular matrix secretion mechanism

PT12.12 - Redirected tropisms of extracellular vesicles and exomeres yield distinct biodistribution profiles

PT12.13 - TRACKING MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES (EVs) IN A IN VIVO CANCER MODEL

PT13.07 - EDTA stabilizes the concentrations of extracellular vesicles during blood collection

PT14.03 - Circular Dichroism-based Exosome (CDEXO) detection microfluidic platform using their assemblies with chiral gold nanoparticles

PT14.06 - High-throughput multiparametric characterization and quantitation of extracellular vesicles by fluorescence-based microfluidic diffusion sizing

PT14.07 - Immunomagnetic isolation of specific subpopulations of exosomes for liquid biopsy via nano-architected porous materials

PT14.09 - Micropatterned Growth Surface Topography Affects Extracellular Vesicle Production

PT14.10 - Using miscroscale thermophoresis and surface plasmon resonance to measure the interactions of extracellular vesicles

PT14.11 - Acoustofluidic separation of complex suspensions

PT14.12 - Nanophotonic platform for cancer-associated exosomal microRNA detection

PT15.01=OP1.01 - Human urinary extracellular vesicles carry surface markers that are indicative of hematopoietic origin

PT15.02=OP1.02 - Cardiovascular risk markers are strongly related to numbers of circulating extracellular vesicles

PT15.04=OP1.04 - Prostanoids impair platelet reactivity, thrombus formation and platelet extracellular vesicle release in patients with pulmonary arterial hypertension

PT15.05=OP1.05 - Nanoflow cytometry identifies an imbalance of epithelium- and neutrophil-derived extracellular vesicles in the airway environment of pediatric cystic fibrosis patients

PT15.06=OP1.06 - The potential of crude extracellular vesicle microRNAs for the diagnosis of community-acquired pneumonia and for the detection of pneumonia-related sepsis as a severe secondary complication

PT15.07=OP1.07 - microRNA exosome cargo from induced sputum: new tool for approaching asthma research

PT15.12=OP1.12 - Extracellular vesicles from adipose tissue end endothelial cells of obese humans share miRNA cargos and increase prostate cancer aggressiveness in conjunction with Twist1

FUJIFILM Wako Pure Chemical Corporation

Malvern

MYRIADE

NanoFCM INC.

RoosterBio, Inc.

System Bio